Recap: HTG Molecular Diagnostics Q1 Earnings

HTG Molecular Diagnostics HTGM reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

HTG Molecular Diagnostics missed estimated earnings by 14.08%, reporting an EPS of $-0.81 versus an estimate of $-0.71.

Revenue was down $251.00 thousand from the same period last year.

Last quarter the company missed on EPS by $0.1 which was followed by a 7.55% drop in the share price the next day.

Here's a look at HTG Molecular Diagnostics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.59	-0.66	-0.77	-1.02
EPS Actual	-0.69	-0.60	-0.65	-0.80
Revenue Estimate	2.97M	2.65M	2.13M	1.69M
Revenue Actual	2.88M	2.52M	2.07M	1.44M

To track all earnings releases for HTG Molecular Diagnostics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.